A clinical study for evaluating the effects of long-term oral intake of lactic acid bacteria on intestinal flora in human subjects.
Not Applicable
- Conditions
- /A
- Registration Number
- JPRN-UMIN000034695
- Lead Sponsor
- House Wellness Foods Corporation Research and Development Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Subjects who have consumed the lactic acid bacteria used in this clinical trial on a daily basis (2) Subjects who are in pregnant or plan to get pregnant, or who are breastfeeding (3) Patients with cancer who have taken radiotherapy, anti-cancer agents and/or hormone agents (4) Patients with thyroid disease who have taken medicines such as Thyradin (5) Patients with rheumatoid arthritis who have taken medicines such as Rheumatrex (6) Subjects who are at risk of having allergic symptoms to test product of this clinical trial (7) Subjects who are participating in the other clinical trial (8) Subjects judged as unsuitable for this clinical trial by the investigator or sub investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method